|Posts on Regator:||3250|
|Posts / Week:||67.9|
|Archived Since:||August 20, 2016|
(Reuters Health) - People who regularly do resistance exercises may get stronger and build more lean muscle mass when they add more protein to their diet, a recent study suggests.
BOSTON (Reuters) - A federal jury handed Amphastar Pharmaceuticals Inc a big win on Friday after it was accused of infringing on a patent held by Momenta Pharmaceuticals Inc through its production of a generic version of the blood-thinner Lovenox.
NEW DELHI (Reuters) - India plans to seek an explanation from Philip Morris International Inc about its marketing practices after Reuters reported that the tobacco giant used tactics that government officials say flout the country's law, a health ministry official said on Friday.
(Reuters Health) - High blood pressure during pregnancy has long been linked to greater odds of redeveloping the condition in middle age, but a new study suggests that the increased risk may exist soon after delivery and persist for decades.
FRANKFURT (Reuters) - Germany's Bayer said on Friday a cancer treatment for patients with a type of tumor often caused by asbestos had failed to meet its main goal in a clinical trial.
(Reuters) - Musician Abhishek Prasad strummed his guitar throughout his neurosurgery to help doctors zero in on the part of the brain being operated on during the first such procedure in India.
GENEVA (Reuters) - An outbreak of cholera in Kenya poses a high risk to the region and a moderate threat globally, the World Health Organization said on Friday, after delegates at two international conferences were hit.
GENEVA (Reuters) - Yemen's cholera outbreak is far from being controlled and may be further exacerbated by the rainy season, even if the rate of new cases appears to be slowing in some hotspots, the World Health Organisation said on Friday.
(Reuters) - European regulators on Friday recommended against granting approval to a breast cancer drug being developed by Nektar Therapeutics and Daiichi Sankyo's German unit.
(Reuters) - A European regulatory panel recommended granting approval to a treatment for HIV infection developed by Janssen-Cilag International, a unit of U.S. drugmaker Johnson & Johnson.
ZURICH (Reuters) - A European Medicines Agency (EMA) panel recommended on Friday approval of a new Novartis drug to be used against a tough-to-cure form of blood cancer as the Swiss drugmaker makes headway on refreshing its oncology portfolio.
(Reuters) - European regulators on Friday recommended approving Pfizer Inc and Merck KGaA's immuno-oncology drug Bavencio to treat a rare type of skin cancer called Merkel cell carcinoma.
LONDON (Reuters) - A nuclear medicine targeting the type of cancer that killed Steve Jobs won a green light from EU regulators on Friday, boosting prospects for its developer Advanced Accelerator Applications.
BEIJING (Reuters) - Organizers of an LGBT conference in China's "gay capital" had to scrap the event this week, the second time in as many months a public seminar aimed at expanding awareness of lesbian, gay bisexual and transgender (LGBT) issues has run into snags.
(Reuters) - Abortion rights groups filed a lawsuit on Thursday seeking to block a Texas law that bans the most common method of second-trimester abortion which critics argue erodes women's rights.
SANTIAGO (Reuters) - Chile's Chamber of Deputies fell one vote short of passing the Senate version of a bill easing the country's strict abortion law, a surprise setback to President Michelle Bachelet and abortion rights advocates.
(Reuters Health) - The weight that Americans typically gain between ages 20 and 50 may raise their risk of developing cancer, heart disease and other major illnesses, according to a new study.
(Reuters Health) - Refugee kids may fare better in their new country when they have support from a variety of people at home, in school and in their community, a small Australian study suggests.
WASHINGTON (Reuters) - U.S. Senate Republicans, scolded by President Donald Trump for failing to overturn Obamacare, tried to salvage their seven-year effort for a new healthcare law on Thursday, but leading senators indicated frustration over shifting goal posts.
WASHINGTON (Reuters) - President Donald Trump on Thursday announced a $500 million investment that Corning Inc is making with pharmaceutical giants Merck and Pfizer to manufacture a new kind of glass for injectable drug vials.